Literature DB >> 23337241

Sensitivity analyses for sparse-data problems-using weakly informative bayesian priors.

Ghassan B Hamra1, Richard F MacLehose, Stephen R Cole.   

Abstract

Sparse-data problems are common, and approaches are needed to evaluate the sensitivity of parameter estimates based on sparse data. We propose a Bayesian approach that uses weakly informative priors to quantify sensitivity of parameters to sparse data. The weakly informative prior is based on accumulated evidence regarding the expected magnitude of relationships using relative measures of disease association. We illustrate the use of weakly informative priors with an example of the association of lifetime alcohol consumption and head and neck cancer. When data are sparse and the observed information is weak, a weakly informative prior will shrink parameter estimates toward the prior mean. Additionally, the example shows that when data are not sparse and the observed information is not weak, a weakly informative prior is not influential. Advancements in implementation of Markov Chain Monte Carlo simulation make this sensitivity analysis easily accessible to the practicing epidemiologist.

Entities:  

Mesh:

Year:  2013        PMID: 23337241      PMCID: PMC3607322          DOI: 10.1097/EDE.0b013e318280db1d

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  27 in total

1.  Putting background information about relative risks into conjugate prior distributions.

Authors:  S Greenland
Journal:  Biometrics       Date:  2001-09       Impact factor: 2.571

2.  Commentary: practical advantages of Bayesian analysis of epidemiologic data.

Authors:  D B Dunson
Journal:  Am J Epidemiol       Date:  2001-06-15       Impact factor: 4.897

3.  Semi-automated sensitivity analysis to assess systematic errors in observational data.

Authors:  Timothy L Lash; Aliza K Fink
Journal:  Epidemiology       Date:  2003-07       Impact factor: 4.822

4.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

5.  Bayesian posterior distributions without Markov chains.

Authors:  Stephen R Cole; Haitao Chu; Sander Greenland; Ghassan Hamra; David B Richardson
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

6.  Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure.

Authors:  Hsin-Yi Weng; Ya-Hui Hsueh; Locksley L McV Messam; Irva Hertz-Picciotto
Journal:  Am J Epidemiol       Date:  2009-04-10       Impact factor: 4.897

7.  Bayesian adjustment for exposure misclassification in case-control studies.

Authors:  Rong Chu; Paul Gustafson; Nhu Le
Journal:  Stat Med       Date:  2010-01-19       Impact factor: 2.373

8.  Software for hierarchical modeling of epidemiologic data.

Authors:  J S Witte; S Greenland; L L Kim
Journal:  Epidemiology       Date:  1998-09       Impact factor: 4.822

Review 9.  Empirical-Bayes and semi-Bayes approaches to occupational and environmental hazard surveillance.

Authors:  S Greenland; C Poole
Journal:  Arch Environ Health       Date:  1994 Jan-Feb

10.  The association of alcohol and tobacco with cancer of the mouth and pharynx.

Authors:  A Z Keller; M Terris
Journal:  Am J Public Health Nations Health       Date:  1965-10
View more
  9 in total

1.  Maximum likelihood, profile likelihood, and penalized likelihood: a primer.

Authors:  Stephen R Cole; Haitao Chu; Sander Greenland
Journal:  Am J Epidemiol       Date:  2013-10-29       Impact factor: 4.897

2.  Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Lawrence S Engel; Jeannette T Bensen; Charles Poole; Amy H Herring; Robert C Millikan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-31       Impact factor: 4.254

3.  The researcher and the consultant: from testing to probability statements.

Authors:  Ghassan B Hamra; Andreas Stang; Charles Poole
Journal:  Eur J Epidemiol       Date:  2015-06-25       Impact factor: 8.082

4.  A Bayesian approach to the g-formula.

Authors:  Alexander P Keil; Eric J Daza; Stephanie M Engel; Jessie P Buckley; Jessie K Edwards
Journal:  Stat Methods Med Res       Date:  2017-03-02       Impact factor: 3.021

5.  Prenatal Exposure to Endocrine-disrupting Chemicals in Relation to Autism Spectrum Disorder and Intellectual Disability.

Authors:  Ghassan B Hamra; Kristen Lyall; Gayle C Windham; Antonia M Calafat; Andreas Sjödin; Heather Volk; Lisa A Croen
Journal:  Epidemiology       Date:  2019-05       Impact factor: 4.822

6.  Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Charles Poole; Jeannette T Bensen; Amy H Herring; Lawrence S Engel; Robert C Millikan
Journal:  Am J Epidemiol       Date:  2013-11-10       Impact factor: 4.897

7.  Nonparametric estimation of the cumulative incidence function under outcome misclassification using external validation data.

Authors:  Jessie K Edwards; Giorgos Bakoyannis; Constantin T Yiannoutsos; Margaret W Mburu; Stephen R Cole
Journal:  Stat Med       Date:  2019-10-24       Impact factor: 2.373

8.  Bayesian methods for clinicians.

Authors:  Razieh Bidhendi Yarandi; Kazem Mohammad; Hojjat Zeraati; Fahimeh Ramezani Tehrani; Mohammad Ali Mansournia
Journal:  Med J Islam Repub Iran       Date:  2020-07-13

9.  Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

Authors:  Jude Moutchia; Pratik Pokharel; Aldiona Kerri; Kaodi McGaw; Shreeshti Uchai; Miriam Nji; Michael Goodman
Journal:  PLoS One       Date:  2020-10-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.